methylprednisolone has been researched along with myelin basic protein in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (21.74) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Barkhof, F; Frequin, ST; Hommes, OR; Lamers, K; Scheltens, P; Valk, J; van Geel, WJ | 1 |
| Barkhof, F; Borm, GF; Frequin, ST; Hommes, OR; Lamers, KJ | 1 |
| Carroll, DJ; Catz, I; Jeffrey, VM; Warren, KG | 1 |
| Hamaguchi, K; Negishi, T; Nomura, K; Ohno, R; Sowa, K; Tanaka, H; Yamashita, T | 1 |
| Carroll, DJ; Catz, I; Warren, KG | 1 |
| Hughes, RA; Taylor, WA; Watts, PM | 1 |
| Hallpike, JF | 1 |
| Bartolucci, AA; Burgard, S; Herman, PK; Kachelhofer, RD; Layton, BA; Whitaker, JN | 1 |
| Beck, RW; Paty, DW; Rolak, LA; Rudick, RA; Tourtellotte, WW; Whitaker, JN | 1 |
| Banik, NL; Hogan, EL; Matzelle, D; Terry, E | 1 |
| Fukaura, H; Hafler, DA; Khoury, SJ; Smith, DR; Takashima, H; Weiner, HL | 1 |
| de Reus, HP; Jongen, PJ; Lamers, KJ | 1 |
| Christiansen, M; Frederiksen, JL; Jensen, J; Sellebjerg, F | 1 |
| Bakalash, S; Kessler, A; Mizrahi, T; Nussenblatt, R; Schwartz, M | 1 |
| Amano, N; Joko, T | 1 |
| Butovsky, O; Hauben, E; Ibarra, A; Schwartz, M | 1 |
| Chen, S; Hsu, CY; Lee, JM; Lee, KY; Xiao, Q; Xu, J; Yan, P | 1 |
| Marković, M; Miljković, D; Miljković, Z; Momcilović, M; Mostarica-Stojković, M; Popadić, D; Ramić, Z; Savić, E | 1 |
| Golomb, MR; Harris, MO; Hattab, EM; Walsh, LE | 1 |
| Fujihara, K; Itoyama, Y; Misu, T; Sato, S; Takahashi, T; Takano, R | 1 |
| de Lastic, AL; Deraos, G; Dimisianos, N; Matsoukas, J; Mouzaki, A; Papathanasopoulos, P; Rodi, M; Sakellaraki, P | 1 |
| Akiyama, H; Hasegawa, Y; Hoshino, M; Mutoh, T; Shima, S; Suzuki, Y; Yamada, K | 1 |
| Begum, Z; Gurusamy, K; Raghunath, G; Sivanesan, S; Subramanian, V; Vijayaraghavan, R | 1 |
3 review(s) available for methylprednisolone and myelin basic protein
| Article | Year |
|---|---|
Effects of high-to-mega-dose synthetic corticosteroids on multiple sclerosis patients with special reference to cerebrospinal fluid antibodies to myelin basic protein.
Topics: Antibodies; Dose-Response Relationship, Drug; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Multiple Sclerosis; Myelin Basic Protein; Prednisone | 1987 |
New treatments for multiple sclerosis.
Topics: Adrenocorticotropic Hormone; Antilymphocyte Serum; Azathioprine; Desensitization, Immunologic; Dietary Fats; Glutens; Humans; Immunosuppressive Agents; Levamisole; Linoleic Acids; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Prednisolone; Transfer Factor | 1980 |
[Demyelinating disease].
Topics: Adrenoleukodystrophy; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Autoimmunity; Benzodiazepines; Diffuse Cerebral Sclerosis of Schilder; Encephalomyelitis, Acute Disseminated; Humans; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Myelin Proteolipid Protein; Neuromyelitis Optica; Olanzapine; Pirenzepine; Pulse Therapy, Drug; Selective Serotonin Reuptake Inhibitors; T-Lymphocytes | 2003 |
2 trial(s) available for methylprednisolone and myelin basic protein
| Article | Year |
|---|---|
Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial.
Topics: Administration, Oral; Adolescent; Adult; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Injections, Intravenous; Longitudinal Studies; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Myelin Basic Protein; Optic Neuritis; Prednisolone; Prospective Studies | 1996 |
Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis.
Topics: Epitopes; Humans; Methylprednisolone; Monitoring, Physiologic; Multiple Sclerosis; Myelin Basic Protein; Neuroprotective Agents; Recurrence; Remission Induction | 1998 |
18 other study(ies) available for methylprednisolone and myelin basic protein
| Article | Year |
|---|---|
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Topics: Adult; Contrast Media; Disability Evaluation; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Organometallic Compounds; Pentetic Acid | 1992 |
CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Topics: Adult; Blood-Brain Barrier; Dose-Response Relationship, Drug; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infusions, Intravenous; Leukocyte Count; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Neurologic Examination; Reference Values | 1992 |
Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations.
Topics: Adrenocorticotropic Hormone; Antibodies; Humans; Immunoglobulin G; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Radioimmunoassay | 1986 |
Immune responses in experimental allergic neuritis treated with corticosteroids.
Topics: Animals; Antibody Formation; Immunity, Cellular; Male; Methylprednisolone; Myelin Basic Protein; Myelin P2 Protein; Neuritis, Autoimmune, Experimental; Rabbits | 1988 |
High-dose methylprednisolone suppresses experimental allergic neuritis in the Lewis rat.
Topics: Animals; Antibodies; Ganglia, Spinal; Immunization; Male; Methylprednisolone; Myelin Basic Protein; Myelin P2 Protein; Nervous System; Nervous System Diseases; Neuritis, Autoimmune, Experimental; Rats; Rats, Inbred Lew | 1989 |
Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment.
Topics: Adult; Aged; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Predictive Value of Tests; Prednisone; Regression Analysis; Treatment Outcome | 1993 |
A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Calpain; Cathepsin B; Cytoskeletal Proteins; In Vitro Techniques; Methylprednisolone; Myelin Basic Protein; Rabbits; Rats; Rats, Sprague-Dawley; Spinal Cord | 1997 |
Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients.
Topics: Adult; Autoantigens; Cell Line; Cyclophosphamide; Female; Humans; Interleukin-4; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Myelin Proteolipid Protein; Tetanus Toxoid; Th2 Cells | 1998 |
Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents; Antigens; CD4-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Immune System; Immunoglobulin G; Leukocyte Count; Male; Matrix Metalloproteinase 9; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Optic Neuritis; Randomized Controlled Trials as Topic; Spinal Cord; Spinal Puncture; Transforming Growth Factor beta | 2000 |
Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma.
Topics: Animals; Autoimmune Diseases; Cell Survival; Cytoprotection; Disease Models, Animal; Eye Proteins; Glaucoma; Immunodominant Epitopes; Intraocular Pressure; Male; Methylprednisolone; Myelin Basic Protein; Ocular Hypertension; Oligopeptides; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Retinal Ganglion Cells; Retinol-Binding Proteins; Uveitis; Vaccination; Vaccines, Synthetic | 2003 |
The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cell Count; Cell Division; Cells, Cultured; Dextrans; Ectodysplasins; Encephalomyelitis, Autoimmune, Experimental; Female; Immunohistochemistry; Immunotherapy, Active; Laminectomy; Membrane Proteins; Methylprednisolone; Motor Activity; Mycobacterium; Myelin Basic Protein; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rhodamines; Species Specificity; Spinal Cord Injuries; T-Lymphocytes; Time Factors; Tryptophan | 2004 |
Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury.
Topics: Analysis of Variance; Animals; Benzothiadiazines; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; L-Lactate Dehydrogenase; Methylprednisolone; Myelin Basic Protein; Neurons; Neuroprotective Agents; Oligodendroglia; Phosphopyruvate Hydratase; Rats; Rats, Long-Evans; RNA, Small Interfering; Spinal Cord Injuries | 2008 |
Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells.
Topics: Animals; Autoimmune Diseases; Concanavalin A; Dose-Response Relationship, Immunologic; Guinea Pigs; Immunization; Interferon-gamma; Interleukin-17; Lymphocyte Activation; MAP Kinase Signaling System; Methylprednisolone; Myelin Basic Protein; Rats; Spinal Cord; T-Lymphocytes; Tissue Extracts | 2008 |
Is it ADEM, POLG, or both?
Topics: Brain; Child, Preschool; Demyelinating Autoimmune Diseases, CNS; Diagnosis, Differential; DNA Mutational Analysis; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Encephalomyelitis, Acute Disseminated; Fatal Outcome; Genetic Markers; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Mitochondrial Diseases; Mutation; Myelin Basic Protein; Oligoclonal Bands; Treatment Failure | 2010 |
Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Topics: Adult; Aged; Antibodies; Aquaporin 4; Astrocytes; Biomarkers; Central Nervous System; Demyelinating Diseases; Disability Evaluation; Encephalomyelitis, Acute Disseminated; Female; Follow-Up Studies; Glial Fibrillary Acidic Protein; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Nerve Growth Factors; Nervous System Diseases; Neurofilament Proteins; Neuromyelitis Optica; Neuroprotective Agents; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Statistics, Nonparametric | 2010 |
Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
Topics: Adult; Autoantigens; CD4-Positive T-Lymphocytes; Female; Flow Cytometry; Forkhead Transcription Factors; Humans; Interleukin-2 Receptor alpha Subunit; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Natalizumab; T-Lymphocytes, Regulatory | 2016 |
[Efficacy of high-dose steroid pulse therapy for anti-galactocerebroside antibody-positive combined central and peripheral demyelination].
Topics: Autoantibodies; Biomarkers; Cell Adhesion Molecules; Central Nervous System Diseases; Demyelinating Diseases; Galactosylceramides; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Myelin Basic Protein; Nerve Growth Factors; Peripheral Nervous System Diseases; Pulse Therapy, Drug; Treatment Outcome | 2017 |
Efficacy of different intensity of aquatic exercise in enhancing remyelination and neuronal plasticity using cuprizone model in male Wistar rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Basic Protein; Neuronal Plasticity; Neuroprotective Agents; Rats; Rats, Wistar; Remyelination | 2022 |